Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan:164:40-49.
doi: 10.1016/j.pbb.2017.06.015. Epub 2017 Jun 27.

Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug

Affiliations
Review

Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug

Frank N Perkins et al. Pharmacol Biochem Behav. 2018 Jan.

Abstract

Drug addiction can be conceptualized as a disorder of maladaptive decision making in which drugs are chosen at the expense of pro-social, nondrug alternatives. The study of decision making in drug addiction has focused largely on the role of impulsivity as a facilitator of addiction, in particular the tendency for drug abusers to choose small, immediate gains over larger but delayed outcomes (i.e., delay discounting). A parallel line of work, also focused on decision making in drug addiction, has focused on identifying the determinants underlying the choice to take drugs over nondrug alternatives (i.e., drug vs. nondrug choice). Both tracks of research have been valuable tools in the development of pharmacotherapies for treating maladaptive decision making in drug addiction, and a number of common drugs have been studied in both designs. However, we have observed that there is little uniformity in the administration regimens of potential treatments between the designs, which hinders congruence in the development of single treatment strategies to reduce both impulsive behavior and drug choice. The current review provides an overview of the drugs that have been tested in both delay-discounting and drug-choice designs, and focuses on drugs that reduced the maladaptive choice in both designs. Suggestions to enhance congruence between the findings in future studies are provided. Finally, we propose the use of a hybridized, experimental approach that may enable researchers to test the effectiveness of therapeutics at decreasing impulsive and drug choice in a single design.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Average normalized values of delayed food pellets as a function of the delay to food delivery for three monkeys that were tested in all three conditions. The symbols represent the predictions of the average discounting function for each condition. From Huskinson et al., 2015; Printed with permission from Elsevier.
Figure 2
Figure 2
The graph depicts an idealized choice study in which subjects choose between a range of doses of cocaine and a fixed amount of a nondrug alternative (represented by food here). Cocaine’s potency as a reinforcer is increased with delay to food delivery and decreased with amphetamine treatment. Amph = Amphetamine

References

    1. Aboujaoude E, Salame WO. Naltrexone: a pain-addiction treatment? CNS Drugs. 2016;30:719–733. - PubMed
    1. Acheson A, de Wit H. Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psyhcopharmacol. 2008;16:113–123. - PMC - PubMed
    1. Acheson A, Reynolds B, Richards JB, de Wit H. Diazepam impairs behavioral inhibition but not delay discounting or risk taking in healthy adults. Exp Clin Psychopharmacol. 2006;14:190–198. - PubMed
    1. Adriani W, Zoratto F, Laviola G. Brain processes in discounting: consequences of adolescent methylphenidate exposure. Curr Top Behav Neurosci. 2012;9:113–143. - PubMed
    1. Asahre RL, McKee SA. Effects of varenicline and bupriopion on cognitive processes among nicotine-deprived smokers. Exp Clin Psychopharmacol. 2012;20:63–70. - PMC - PubMed

Publication types

MeSH terms

Substances